SINTERYX PHARMA
InactiveActs, filings and financial milestones
2025
03-11
Bankruptcy
Bankruptcy closure (by liquidation)
Enterprise Court of Antwerp, Hasselt division · judgment of 28-10-2025
2024
19-02
Bankruptcy
Bankruptcy declared
Enterprise Court of Antwerp, Hasselt division · judgment of 08-02-2024
2023
09-08
micro format · 9 days late
2022
31-12
Financial
Weakest financial yearnet -€134,631
The net result drops to -€134,631, the lowest from 2020 to 2022.
31-12
Financial
Liquidity more than 8 timescurrent ratio 15.29
The current ratio rises from 1.89 to 15.29. Short-term debt falls from €37,924 to €10,502.
05-07
micro format · 26 days before the deadline
17-02
Gazette deed
Resignation: Harmen Jans (director)Appointment: Natural Supplement BV (director) · Permanent representative: Harmen Jans3 points ▸
Gazette deed
Resignation: Harmen Jans (director)
Appointment: Natural Supplement BV (director) · Permanent representative: Harmen Jans3 points ▸
- Director resignation, Harmen Jans (director)
- Director appointment, Natural Supplement BV (director)
- Permanent representative, Harmen Jans
2021
31-12
Financial
Back to profitnet €27,494
The net result is €27,494, after one loss-making year.
31-12
Financial
Liquidity more than doubledcurrent ratio 1.89
The current ratio rises from 0.77 to 1.89. Short-term debt falls from €59,893 to €37,924.
30-06
micro format · 31 days before the deadline
2020
04-03
2 publications in the Belgian Official Gazette, the last on 17-02-2022
SignalFinancial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank